Methods and Results In this study, we found that SAL alleviated lipid accumulation and
inflammatory response in primary hepatocytes after palmitic acid/oleic acid (PO) stimulation …

Background and Aims NASH is becoming a leading cause of liver cirrhosis and HCC.
Salidroside (p‐hydroxyphenethyl‐β‐D‐glucoside; SAL) has various biological and …

Tartaric acid (TA) has been shown beneficial effects on blood pressure and lipid levels.
However, its effect on non-alcoholic fatty liver disease (NAFLD) remains unknown. This …

Nonalcoholic fatty liver disease (NAFLD) is caused by ectopic fat accumulation in the liver.
NAFLD is associated with hepatic inflammation and oxidative stress, resulting in …

Dietary habit is highly related to nonalcoholic fatty liver disease (NAFLD). Low-fat–high-
carbohydrate (LFHC) diets could induce lean NAFLD in Asians. Previously, we found that a …

Recent experimental studies and clinical trials have shown that hepatic cholesterol
metabolic disorders are closely related to the development of nonalcoholic fatty liver disease …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease, sometimes ranges from simple steatosis to nonalcoholic steatohepatitis (NASH) …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease in
developed countries. Recent studies indicated that the modification of gut microbiota plays …

Non‑alcoholic fatty liver disease (NAFLD) is characterized by diffuse fatty acid degeneration
and excess fat accumulation in the liver. Notably, the currently available medications used to …

Background Intake of fish oil rich in n-3 polyunsaturated fatty acids (PUFAs) is believed to be
beneficial against development of non-alcoholic fatty liver disease (NAFLD). However, the …